Xeris Biopharma Holdings Inc (XERS)

Long-Term Debt

$219.35M

Quarterly · Period ending: · USD

XERS logo

XERS Long-Term Debt

Latest reported$219.35M
XERS Quarterly Long-Term Debt ($0.00 → $219.35M)
High-resolution chart · PNG

XERS long-term debt history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Xeris Biopharma Holdings Inc Long-Term Debt — Quarterly (USD)
Period endingLong-Term Debt (USD)
219,349,000
31,058,000
31,531,000
31,991,000
251,067,000
250,675,000
250,265,000
249,866,000
264,497,000
264,071,000
225,696,000
225,577,000
223,053,000
196,969,000
196,477,000
138,507,000
138,068,000
137,639,000
88,067,000
87,713,000
87,478,000
87,272,000
87,021,000
119,391,000
109,476,000
58,485,000
58,305,000
58,124,000
29,403,000
32,141,000
31,890,000
31,642,000
18,167,000
18,051,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.